Loading company…
Mycovia Pharmaceuticals develops treatments for serious fungal infections.
Founded in 2005 and based in Durham, US, Mycovia Pharmaceuticals develops treatments for serious fungal infections. Its therapies target patients with challenging infections, serving healthcare institutions in North America and selected international markets. The company raised USD 60.00 mn in a Series D round, with Astellas Venture Management and Novartis Venture Fund among the investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in